Literature DB >> 2425332

An investigation of the protein components of amyloid using immunoperoxidase and permanganate methods on tissue sections.

L M Looi.   

Abstract

Amyloid deposits in tissue from 8 patients with generalized primary amyloidosis, 11 patients with generalized secondary amyloidosis, 11 nasopharyngeal carcinomas, 11 basal cell carcinomas, 4 islet cell tumours, 4 medullary carcinomas of the thyroid and 9 cases of lichen amyloidosis were studied using the indirect immunoperoxidase and peroxidase-antiperoxidase methods with specific antisera against Amyloid A (AA) protein and human immunoglobulin lambda and kappa light chains. The permanganate method of Wright was also applied to tissue sections. Positive staining for AA protein was observed only in secondary amyloidosis. There was excellent correlation between AA positivity and permanganate sensitivity. Positivity for immunoglobulin light chains was not observed in secondary amyloidosis but was noted in 5 (63%) cases of primary amyloidosis and 18-27% of intratumour amyloidosis. Lichen amyloidosis did not stain for AA protein or light chains. It is shown that assessment of the permanganate reaction and AA positivity of amyloid deposits can reliably differentiate secondary from primary amyloidosis and may contribute significantly to selection of patients for appropriate therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425332     DOI: 10.3109/00313028609090841

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  2 in total

1.  Case report 480: Periosteal amyloid tumor.

Authors:  S O Yoshida; R Karjoo; M R Johnstone
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

2.  Renal Amyloidosis: Epidemiological, Clinical, and Laboratory Profile in Adults from One Nephrology Center.

Authors:  Hayet Kaaroud; Amel Harzallah; Mariem Hajji; Soumaya Chargui; Samia Barbouch; Sami Turki; Raja Trabelsi; Rim Goucha; Fatma Ben Moussa; Hedi Ben Maiz; Fethi Ben Hamida; Ezzeddine Abderrahim
Journal:  Int J Nephrol       Date:  2022-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.